Skip to main content
SpringerLink
Log in

Good response to mycophenolate mofetil on treatment of interstitial lung disease in polymyositis associated with antisynthetase syndrome positive for anti-EJ and anti-Ro52 antibodies

  • Letter to the Editor
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Petri MH, Satoh M, Martin-Marquez BT, Vargas-Ramirez R, Jara LJ, Saavedra MA et al (2013) Implications in the difference of anti-Mi-2 and -p155/140 autoantibody prevalence in two dermatomyositis cohorts from Mexico City and Guadalajara. Arthritis Res Ther 15:R48. https://doi.org/10.1186/ar4207

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Shamim EA, Rider LG, Pandey JP, O’Hanlon TP, Jara LJ, Samayoa EA, Burgos-Vargas R, Vazquez-Mellado J, Alcocer-Varela J, Salazar-Paramo M, Kutzbach AG, Malley JD, Targoff IN, Garcia-De la Torre I, Miller FW (2002) Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis. Arthritis Rheum 46:1885–1893. https://doi.org/10.1002/art.10358

    Article  PubMed  Google Scholar 

  3. Cottin V, Brown KK (2019) Interstitial lung disease associated with systemic sclerosis (SSc-ILD). Respir Res 20:13. https://doi.org/10.1186/s12931-019-0980-7

    Article  PubMed  PubMed Central  Google Scholar 

  4. Adler S, Huscher D, Siegert E, Allanore Y, Czirjak L, DelGaldo F et al (2018) Systemic sclerosis associated interstitial lung disease-individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group. Arthritis Res Ther 20:17. https://doi.org/10.1186/s13075-018-1517-z

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Barba T, Fort R, Cottin V, Provencher S, Durieu I, Jardel S, Hot A, Reynaud Q, Lega JC (2019) Treatment of idiopathic inflammatory myositis associated interstitial lung disease: a systematic review and meta-analysis. Autoimmun Rev 18:113–122. https://doi.org/10.1016/j.autrev.2018.07.013

    Article  PubMed  Google Scholar 

  6. Morganroth PA, Kreider ME, Werth VP (2010) Mycophenolate mofetil for interstitial lung disease in dermatomyositis. Arthritis Care Res 62:1496–1501. https://doi.org/10.1002/acr.20212

    Article  Google Scholar 

  7. Giannini M, Notarnicola A, Dastmalchi M, Lundberg IE, Lopalco G, Iannone F (2016) Heterogeneous clinical spectrum of interstitial lung disease in patients with anti-EJ anti-synthetase syndrome: a case series. Clin Rheumatol 35:2363–2367. https://doi.org/10.1007/s10067-016-3258-1

    Article  PubMed  Google Scholar 

  8. Cavagna L, Nuno L, Scire CA, Govoni M, Longo FJ, Franceschini F et al (2015) Clinical spectrum time course in anti Jo-1 positive antisynthetase syndrome: results from an international retrospective multicenter study. Medicine (Baltimore) 94:e1144. https://doi.org/10.1097/MD.0000000000001144

    Article  CAS  Google Scholar 

  9. Tampoia M, Notarnicola A, Abbracciavento L, Fontana A, Giannini M, Humbel RL, Iannone F (2016) A new immunodot assay for multiplex detection of autoantibodies in a cohort of Italian patients with idiopathic inflammatory myopathies. J Clin Lab Anal 30:859–866. https://doi.org/10.1002/jcla.21948

  10. Bauhammer J, Blank N, Max R, Lorenz HM, Wagner U, Krause D, Fiehn C (2016) Rituximab in the treatment of Jo1 antibody-associated antisynthetase syndrome: anti-Ro52 positivity as a marker for severity and treatment response. J Rheumatol 43:1566–1574. https://doi.org/10.3899/jrheum.150844

    Article  CAS  PubMed  Google Scholar 

  11. Lundberg IE, Tjarnlund A, Bottai M, Werth VP, Pilkington C, de Visser M et al (2017) 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheum 69:2271–2282. https://doi.org/10.1002/art.40320

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Instituto de Investigación en Reumatología y Del Sistema Músculo Esquelético, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada No. 950, Colonia Independencia, 44340, Guadalajara, Jalisco, México

    Erika A. Martínez-García, Andrea V. Lujano-Benítez & Mónica Vázquez-Del Mercado

  2. Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, México

    Erika A. Martínez-García

  3. UDG-CA-703 Inmunología y Reumatología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, México

    Erika A. Martínez-García, Ignacio García-De La Torre & Mónica Vázquez-Del Mercado

  4. Departamento de Inmunología y Reumatología, Hospital General de Occidente and Universidad de Guadalajara, Guadalajara, Jalisco, México

    Ignacio García-De La Torre

  5. Hospital Civil de Guadalajara “Juan I. Menchaca”, Servicio de Reumatología, 004086, PNPC, CONACyT, Guadalajara, Jalisco, México

    Mónica Vázquez-Del Mercado

Authors
  1. Erika A. Martínez-García
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrea V. Lujano-Benítez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ignacio García-De La Torre
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mónica Vázquez-Del Mercado
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mónica Vázquez-Del Mercado.

Ethics declarations

The patient gave the consent to publish her clinical case.

Disclosures

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Martínez-García, E.A., Lujano-Benítez, A.V., García-De La Torre, I. et al. Good response to mycophenolate mofetil on treatment of interstitial lung disease in polymyositis associated with antisynthetase syndrome positive for anti-EJ and anti-Ro52 antibodies. Clin Rheumatol 39, 2837–2839 (2020). https://doi.org/10.1007/s10067-020-05075-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-020-05075-7

Search

Navigation